DoW Prostate Cancer, Data Science Award
DoW Prostate Cancer, Data Science Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 02 Sep 2026. Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Data Science Award (DSA) supports research that develops or uses quantitative and analytical approaches, processes and/or systems to obtain knowledge and insight from large and/or complex sets of prostate cancer data in one…
Opportunity overview
- Project name
- DoW Prostate Cancer, Data Science Award
- Donor
- Defense Health Agency Contracting Activity - DHACA
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is DoW Prostate Cancer, Data Science Award?
DoW Prostate Cancer, Data Science Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 02 Sep 2026. Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Data Science Award (DSA) supports research that develops or uses quantitative and analytical approaches, processes and/or systems to obtain knowledge and insight from large and/or complex sets of prostate cancer data in one…
Who is funding DoW Prostate Cancer, Data Science Award?
DoW Prostate Cancer, Data Science Award is funded by Defense Health Agency Contracting Activity - DHACA.
When is the deadline to apply for DoW Prostate Cancer, Data Science Award?
The application deadline is 02 Sep 2026 00:00 (UTC).
Where will the DoW Prostate Cancer, Data Science Award project take place?
The project location(s) are: United States.
How can I apply for DoW Prostate Cancer, Data Science Award?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.